CONNECTING RESEARCHERS AND INVESTORS

The Longevity Investor Network is an initiative by LEAF to bring together investors and promising biotech startups focused on aging. The network is organized by LEAF board member Javier Noris and meets once a month to listen to presentation pitches from new companies seeking investment funding.

The Longevity Investor Network leverages the backgrounds of 50+ investors to invest in exemplary leaders who are founding dynamic companies in the aging and rejuvenation sectors.

OUR PHILOSOPHY

OUR PROCESS

We hold monthly virtual pitch meetings with investors from across the globe. Each meeting typically lasts just under an hour and consists of two or three longevity-focused companies that are given the opportunity to pitch to the network. We finalize the meeting with a Q&A series from the investor group as we try to get a good understanding about each company and evaluate it on its merits. Here is a summary of our broader process:

EXAMPLES OF PAST PRESENTING COMPANIES

 

 

 

JOIN THE LONGEVITY INVESTOR NETWORK

If you are an investor and are interested in joining the Longevity Investor Network, we would love to hear from you. Please contact us by clicking on “Join Us!” graphic below.

HIGHLIGHTED NETWORK MEMBERS

Sebastian Aguiar – Apollo Ventures

Expected Longevity Investments in 2019:  1-2

Typical Check Size:  Seed investments at $1-5M

Longevity Investments: Aeonian Pharmaceuticals, Cleara Biotech, Samsara Therapeutics, Telos Biotech.

Karl Pfleger- Angel Investor

Expected Longevity Investments in 2019: 3-8 directly longevity-related, plus 2-4 peripherally related.

Typical Check Size: $50k for longevity companies, possibly rising in 2019.

Longevity Investments: AgeX, Oisin, Juvena, Retrotope, Repair and more.

Bill Cherman – Front Seat Capital / Angel

Expected Longevity Investments in 2019: 0-10

Typical Check Size: $25k+

Longevity Investments: Repair Biotechnologies (co-founder), Antoxerene, Leucadia, Juvena, Forever Labs, Dante Labs, Sixfold, Covalent, Auctus.

Paul Spiegel- Angel Investor

Expected Longevity Investments in 2019: 2-4

Typical Check Size: $10k

Longevity Investments: Immusoft, Oisin, others

Mikel López de Torre – Angel Investor

Expected Longevity Investments in 2019: 0-2

Typical Check Size: $30k

Anar Isman- Angel Investor

Expected Longevity Investments in 2019: 2-3

Typical Check Size: $25-50k

Dillan DiNardo – UPMC Enterprises VC

Expected Longevity Investments in 2019: 2+

Typical Check Size: $50K – $15M

Joe Betts-Lacroix – YC Combinator / Angel

Expected Longevity Investments in 2019: 1-2

Typical Check Size: $25K

Longevity Investments: Spring Discovery

Eric Uhrhane – Angel Investor

Expected Longevity Investments in 2019: 0-2

Typical Check Size: $25K

Longevity Investments: Repair Biotechnologies [$50k, 2018], Oisin [$125K, 2016]

Avi (Abraham) Rosenbaum, Ph.D. – Tectonic Capital

Expected Longevity Investments in 2019: 1-2

Typical Check Size: $250K

Andrew Allan – Angel Investor

Expected Longevity Investments in 2019: 0-2

Typical Check Size: $25K

Longevity Investments: Unity, AgeX, Restorbio, Biotime

Jonathan Friedlander – Digitalis Ventures

Expected Longevity Investments in 2019: 1-2

Typical Check Size: $250K – 2M

Longevity Investments: Rejuvenate Bio

Yizhen Dong – 11.2 Capital

Expected Longevity Investments in 2019: 2-3

Typical Check Size: $500K-$3M

Frank Schueler – Angel Investor

Expected Longevity Investments in 2019: 4-7

Typical Check Size: 50K EUR – 3M EUR

Longevity Investments: Elevian, Antoxerene, AgeX, Oisin, Lysoclear, CellAge, FoxBio

NETWORK MEMBERS